Plain-English translation of NCT06993571 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
This study doesn't follow the usual testing phases — it may be an observational study or a different type of research.
This trial is testing a new device called transcranial alternating current stimulation (tACS) that delivers gentle electrical pulses to your brain through electrodes placed on your scalp. The device is designed to work with your brain's natural rhythms to help reduce the hand tremor associated with Parkinson's disease. This is a non-invasive treatment — meaning there's no surgery involved — and researchers are testing whether it can help patients whose tremor doesn't respond well to current medications.
Many people with Parkinson's disease experience hand tremor that is difficult to control with standard medications alone. While deeper brain surgery (called deep brain stimulation) can help, it carries risks and isn't right for everyone. This trial exists to see if a newer, non-invasive electrical stimulation approach could offer a safer alternative to help reduce tremor.
You likely qualify if…
You likely don't qualify if…
You will receive transcranial alternating current stimulation sessions where electrodes are placed on your scalp and gentle electrical pulses are delivered to your brain. You may receive active stimulation (where the device is turned on), sham stimulation (where the device is not active, so you're part of the control group), or active stimulation without phase alignment. The study involves a small group of 10 participants total, and the research team will measure changes in your tremor before, during, and after treatment.
AI-generated summary from trial data · Sep 3, 2026 · Not medical advice
Germany